Autoimmune diseases, affecting over 800 million people worldwide, result from the immune system attacking self-tissues, leading to chronic conditions like rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease. Driven by genetic, environmental, and immunological factors, these disorders involve key mediators such as interleukins, autoantibodies, and T/B cell dysregulation. abinScience provides high-quality proteins and antibodies to support research into these mechanisms. While no cures exist, targeted therapies, including anti-TNF-α, IL-6, and JAK inhibitors, significantly improve patient outcomes.
